euro adhoc: Curanum AG / Financial Figures/Balance Sheet / Publishing the figures of Q1/ 2008

--------------------------------------------------------------------------------
Disclosure announcement transmitted by euro adhoc. The issuer is responsible
for the content of this announcement.
--------------------------------------------------------------------------------

3-month report

14.05.2008

Ad hoc announcement

CURANUM raises revenue by 12.5%

The CURANUM Group grew its first-quarter earnings from Euro 56.6
million to Euro 63.7 million, which represents a year-on-year rise of
12.5%. The increase in revenue, which reflects the first-time
consolidation of the Elisa Group as of January 1, 2008, nevertheless
fell short of our expectations. The Group occupancy rate dropped to
around 88% due to a greater level of competitive activities, few
competitor operations leaving the market, and an increase in
mortalities.

As a consequence, earnings before interest, tax, depreciation and
amortization (EBITDA) fell in the first quarter from Euro 8.1 million
in 2007 to Euro 7.9 million. The EBITDA margin declined from 14.3% to
12.4%, which was due to both the lower occupancy and the budgeted
integration expense for the new facilities. Depreciation and
amortization rose slightly from Euro 2.1 million to Euro 2.3
million, and EBIT operating earnings in the first quarter amounted to
Euro 5.5 million (previous year: Euro 6.0 million). Following a net
financial result of - Euro 2.5 million (previous year: - Euro 2.0
million), and the lower tax expense of Euro 0.9 million (previous
year: Euro 1.5 million), net income amounted to Euro 2.2 million
(previous year: Euro 2.4 million).

As a result of higher expenses arising from depreciation,
amortization, and interest, accompanied by lower actual outgoing
payments, cash flow rose from Euro 3.5 million in the first quarter
of 2007 to Euro 4.1 million in the first quarter of 2008. Cash and
cash equivalents increased from Euro 4.2 million to Euro 10.2 million
in a quarter-on-quarter comparison, and equity grew from Euro 41.4
million to Euro 64.7 million as of March 31, 2008.

Through the creation of the TQM level last year, and the resultant
significant improvement in operating management, we have already
achieved successes in terms of improved quality, and we are assuming
this progress will continue. This has unfortunately not yet been
reflected in occupancy, but we are convinced that quality will prove
its value in the long term. We have strengthened our marketing and
sales measures, and expanded our extensive education and training
program. This is why we are confident that we will further improve
our occupancy position over the course of the year, and reach our
annual budget.

Munich, May 13, 2008

The Management Board

|Key figures IFRS as of March 31, 2008| | | |
| | | | | |
| | | | | |
|mil. Euro | |Q1/ 2008|Q1/ 2007 |FY 2007 |
| | | | | |
|Sales | |63.7 |56.6 |230.1 |
|Staff costs | |31.5 |27.9 |115.1 |
|Rental costs | |13.8 |11.1 |45.1 |
|EBITDA | |7.9 |8.1 |30.7 |
|in % of sales | |12.4% |14.3% |13.3% |
|Depreciation | |2.3 |2.1 |8.5 |
|EBIT | |5.5 |6.0 |22.1 |
|in % of sales | |8.6% |10.6% |9.6% |
|Financial result | |-2.5 |-2.0 |-9.4 |
|EBT | |3.0 |4.0 |12.7 |
|Net profit | |2.2 |2.4 |4.8 |
|EPS (Euro) | |0.07 |0.08 |0.15 |
| | | | | |
|Cashflow | |4.1 |3.5 |10.5 |
|CPS (Euro) | |0.13 |0.11 |0.16 |
| | | | | |
|Cash and cash equivalents | |10.2 |4.2 |25.6 |
|Equity capital | |64.7 |41.4 |62.5 |
|in % of balance sum | |25.8% |19.3% |26.0% |
|Balance sheet total | |250.8 |214.9 |239.7 |
| | | | | |

end of announcement euro adhoc
--------------------------------------------------------------------------------

ots Originaltext: Curanum AG
Im Internet recherchierbar: http://www.presseportal.de

Further inquiry note:

Bettina Pöschl

Tel. +49(0)89-242065-69

E-Mail: bettina.poeschl@curanum.de

Branche: Healthcare Providers
ISIN: DE0005240709
WKN: 524070
Index: SDAX, CDAX, Classic All Share, Prime All Share
Börsen: Börse Frankfurt / regulated dealing/prime standard
Börse Berlin / free trade
Börse Hamburg / free trade
Börse Stuttgart / free trade
Börse Düsseldorf / free trade
Börse München / regulated dealing